We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleMHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.AuthorsIlkovitch D; Ostrand-Rosenberg SPublicationCancer immunology, immunotherapy : CII, 2004, Vol 53, Issue 6, p525ISSN0340-7004Publication typearticleDOI10.1007/s00262-003-0486-4